PROGENICS PHARMACEUTICALS IN - COM (PGNX)

CUSIP: 743187106

Q2 2020 13F Holders as of 30 Jun 2020

Type / Class
Equity / COM
Total 13F shares
168,176
Share change
-58,159,103
Total reported value
$177,000
Price per share
$3.75
Number of holders
3
Value change
-$221,048,659
Number of sells
118

Quarterly Holders Quick Answers

What is CUSIP 743187106?
CUSIP 743187106 identifies PGNX - PROGENICS PHARMACEUTICALS IN - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of PROGENICS PHARMACEUTICALS IN - COM (PGNX) as of Q2 2020

As of 30 Jun 2020, PROGENICS PHARMACEUTICALS IN - COM (PGNX) was held by 3 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 168,176 shares. The largest 3 holders included NEW YORK STATE TEACHERS RETIREMENT SYSTEM, EVERENCE CAPITAL MANAGEMENT INC, and Daiwa Securities Group Inc.. This page lists 3 institutional shareholders reporting positions in this security for the Q2 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.